E-ISSN 2277-338X
 

Original Research
Online Published: 07 Feb 2020
 


A prospective study on treatment of recurrent epithelial ovarian cancer with gemcitabine and pegylated liposomal doxorubicin

.


Abstract
No abstract available


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

. A prospective study on treatment of recurrent epithelial ovarian cancer with gemcitabine and pegylated liposomal doxorubicin. Int J Med Sci Public Health. 2020; 9(3): 224-228. doi:10.5455/ijmsph.2020.12348201930012020


Web Style

. A prospective study on treatment of recurrent epithelial ovarian cancer with gemcitabine and pegylated liposomal doxorubicin. https://www.ijmsph.org/?mno=78809 [Access: October 13, 2025]. doi:10.5455/ijmsph.2020.12348201930012020


AMA (American Medical Association) Style

. A prospective study on treatment of recurrent epithelial ovarian cancer with gemcitabine and pegylated liposomal doxorubicin. Int J Med Sci Public Health. 2020; 9(3): 224-228. doi:10.5455/ijmsph.2020.12348201930012020



Vancouver/ICMJE Style

. A prospective study on treatment of recurrent epithelial ovarian cancer with gemcitabine and pegylated liposomal doxorubicin. Int J Med Sci Public Health. (2020), [cited October 13, 2025]; 9(3): 224-228. doi:10.5455/ijmsph.2020.12348201930012020



Harvard Style

(2020) A prospective study on treatment of recurrent epithelial ovarian cancer with gemcitabine and pegylated liposomal doxorubicin. Int J Med Sci Public Health, 9 (3), 224-228. doi:10.5455/ijmsph.2020.12348201930012020



Turabian Style

. 2020. A prospective study on treatment of recurrent epithelial ovarian cancer with gemcitabine and pegylated liposomal doxorubicin. International Journal of Medical Science and Public Health, 9 (3), 224-228. doi:10.5455/ijmsph.2020.12348201930012020



Chicago Style

. "A prospective study on treatment of recurrent epithelial ovarian cancer with gemcitabine and pegylated liposomal doxorubicin." International Journal of Medical Science and Public Health 9 (2020), 224-228. doi:10.5455/ijmsph.2020.12348201930012020



MLA (The Modern Language Association) Style

. "A prospective study on treatment of recurrent epithelial ovarian cancer with gemcitabine and pegylated liposomal doxorubicin." International Journal of Medical Science and Public Health 9.3 (2020), 224-228. Print. doi:10.5455/ijmsph.2020.12348201930012020



APA (American Psychological Association) Style

(2020) A prospective study on treatment of recurrent epithelial ovarian cancer with gemcitabine and pegylated liposomal doxorubicin. International Journal of Medical Science and Public Health, 9 (3), 224-228. doi:10.5455/ijmsph.2020.12348201930012020